New Horizon Medical Solutions
New Horizon Medical Solutions is a national advanced wound-care platform delivering biologics, devices, diagnostics, clinical education, reimbursement support, and operational infrastructure to outpatient, post-acute, surgical, and wound-care providers. The company partners with leading manufacturers and healthcare organizations to support compliant adoption of advanced wound-care technologies across the full care continuum.
Industries
Nr. of Employees
medium (51-250)
Products
Dehydrated, dual-layer placental allograft combining amniotic and chorionic membranes for structural coverage of complex wounds. Sterile, shelf-stable, designed for ease of use and anatomical contouring. Suitable for diabetic foot ulcers, venous leg ulcers, pressure ulcers, surgical wounds, trauma, and dermal defects.
Handheld, FDA 510(k)-cleared imaging device using ultraviolet light for non-contact visualization of elevated wound surface bacterial load via autofluorescent signatures.
Single-layer, transparent negative pressure wound dressing with embossed surface for consistent pressure distribution and visual wound assessment, operates without foam or gauze fillers.
Sterile, single-use kit enabling clinicians to harvest, mechanically prepare, and apply split-thickness skin micrografts for efficient wound coverage and reduced donor site size. Procedure can be performed under local anesthesia and outside the operating room.
Sterile, shelf-stable amniotic membrane allograft derived from human placenta for wound protection in acute and chronic wounds.
Shelf-stable, dual-sided lyophilized amniotic membrane preserving native growth factors for regenerative support in various wound settings.
Dehydrated, dual-layer placental allograft combining amniotic and chorionic membranes for structural coverage of complex wounds. Sterile, shelf-stable, designed for ease of use and anatomical contouring. Suitable for diabetic foot ulcers, venous leg ulcers, pressure ulcers, surgical wounds, trauma, and dermal defects.
Handheld, FDA 510(k)-cleared imaging device using ultraviolet light for non-contact visualization of elevated wound surface bacterial load via autofluorescent signatures.
Single-layer, transparent negative pressure wound dressing with embossed surface for consistent pressure distribution and visual wound assessment, operates without foam or gauze fillers.
Sterile, single-use kit enabling clinicians to harvest, mechanically prepare, and apply split-thickness skin micrografts for efficient wound coverage and reduced donor site size. Procedure can be performed under local anesthesia and outside the operating room.
Sterile, shelf-stable amniotic membrane allograft derived from human placenta for wound protection in acute and chronic wounds.
Shelf-stable, dual-sided lyophilized amniotic membrane preserving native growth factors for regenerative support in various wound settings.
Services
Comprehensive revenue cycle management including claims processing, coding, audit defense, payer contracting, credentialing, and patient billing for healthcare practices.
Assessment and implementation of workflow improvements, digital technology integration, and staff training for operational efficiency and enhanced patient outcomes.
Training for healthcare providers and staff on proper use of biologic wound care products, application protocols, and clinical workflows.
Comprehensive revenue cycle management including claims processing, coding, audit defense, payer contracting, credentialing, and patient billing for healthcare practices.
Assessment and implementation of workflow improvements, digital technology integration, and staff training for operational efficiency and enhanced patient outcomes.
Training for healthcare providers and staff on proper use of biologic wound care products, application protocols, and clinical workflows.
Expertise Areas
- Wound care and regenerative medicine
- Biologic therapies for chronic and acute wounds
- Trauma, burn, surgical, oncology, and reconstructive wound management
- Medical billing, revenue cycle, and compliance
Key Technologies
- Lyophilized amniotic membrane processing
- Tri-layer placental allograft construction
- Acellular dermal matrix for scaffolding
- Near-infrared tissue oxygenation imaging
Key People
Founder & CEO
COO
Medical Director, Co-lead, Medical Advisory Board
Managing Director, New Horizon Billing Solutions
SVP, Enterprise Provider Solutions & Market Access
Danny Bazaan
CFO
Founder & CEO
COO
Medical Director, Co-lead, Medical Advisory Board
Managing Director, New Horizon Billing Solutions
SVP, Enterprise Provider Solutions & Market Access
Danny Bazaan
CFO
News & Updates
Acquisition of a leader in lyophilized amniotic membrane technology to enhance biologics offerings.
Acquired advanced negative pressure wound therapy and micro-grafting devices to expand wound care portfolio.
Introduced a premium amniotic-chorionic membrane allograft for advanced wound care.
Launched single- and dual-layer amniotic membrane allografts supported by new CMS Q codes.
Established a multidisciplinary board to guide clinical strategy, product validation, and regulatory alignment.
Launch of a tri-layer placental-derived allograft for wound management.
Acquisition of a leader in lyophilized amniotic membrane technology to enhance biologics offerings.
Acquired advanced negative pressure wound therapy and micro-grafting devices to expand wound care portfolio.
Introduced a premium amniotic-chorionic membrane allograft for advanced wound care.
Launched single- and dual-layer amniotic membrane allografts supported by new CMS Q codes.
Established a multidisciplinary board to guide clinical strategy, product validation, and regulatory alignment.
Launch of a tri-layer placental-derived allograft for wound management.